Cha Biotech announced on January 14 that it has decided to conduct a third-party allotment capital increase to raise approximately 10 billion won in operating funds.



A total of 771,664 new common shares will be issued at 12,959 won per share. The third-party allotment recipient is LG CNS Co., Ltd.

Cha Biotech to Raise 10 Billion Won Through Capital Increase... Third-Party Allotment to LG CNS View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing